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The increasing incidence of obesity, leading to metabolic complications is now 
recognized as a major public health problem. The adipocytes are not merely energy-
storing cells, but they play crucial roles in the development of the so-called metabolic 
syndrome and cardiovascular diseases due to the adipocyte-derived bioactive fac-
tors, such adipokines, cytokines and growth factors [1]. Most of adipokines, which 
affect whole-body homeostasis, are pro-inflammatory, whereas a small number of 
anti-inflammatory adipokines, including adiponectin exert beneficial actions on obese 
complications. The dysregulated production and secretion of adipokines seen in obe-
sity is linked to the pathogenesis of various disease processes [2]. New emerging data 
showed that melatonin, pineal gland indoleamine, play an important role in body 
weight regulation and energy metabolism [3].
Lean and obese mice (ob/ob) received melatonin (100 mg/kg/day) or vehicle in 
drinking water for 8 weeks. In obese mice we observed a significant increase in fat 
depots and a deregulation of adipokines and cytokines fat expressions. In particular, 
we observed a significant reduction of adiponectin and an increase of resistin and vis-
fatin at adipose tissue level. Melatonin administration for 8 weeks reduced fat accu-
mulation and restored the correct adipokines expression, modulating in turn the vas-
cular tone and homeostasis. 
These results indicate that melatonin counteracts some of the disrupting effects of 
obesity.
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